GlaxoSmithKline PLC/ US37733W1053 /
2024-04-19 9:59:57 PM | Chg. +0.47 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.74USD | +1.18% | 45,922 Turnover: 1.82 mill. |
-Bid Size: - | -Ask Size: - | 74.42 bill.USD | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
02-22
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoi...
GlobeNewswire
01-07
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generat...
GlobeNewswire
2023-12-21
Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-09-28
OncoC4 Strengthens Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer
GlobeNewswire
2023-09-21
Spherix Global Insights Announces New Leadership to Drive Growth and Innovation